FUJIFILM Holdings

FUJIFILM Holdings selected as a
“Health & Productivity Stock” for the first time

News Release

March 4, 2021

[Logo]Health & Productivity Management

TOKYO, March 4, 2021 – FUJIFILM Holdings Corporation (President: Kenji Sukeno) is pleased to announce that the company has been selected as a “Health & Productivity Stock” for the first time in a joint program run by the Ministry of Economy, Trade and Industry (METI) and the Tokyo Stock Exchange (TSE).

The METI and TSE launched the Health & Productivity Stock Selection in 2015 to recognize TSE-listed enterprises that actively promote “Health & Productivity Management*1,” an initiative focusing on and strategically carrying out efforts regarding employees’ health from a management perspective.

In September 2019, FUJIFILM Holdings adopted the “Fujifilm Group Employee Wellness Declaration” to strongly promote Health & Productivity Management, recognizing that one of its management tasks is to maintain and promote employee wellness, which lays the foundation for realizing the Fujifilm Group’s corporate philosophy and vision. The company has worked on building a health-oriented corporate culture while also implementing employee wellness measures including setting Group-wide numerical targets in five categories, namely lifestyle diseases, cancer, smoking, mental health and working hours.

<Fujifilm Employee Wellness Declaration>

To enhance our leading position in consistently demonstrating new value for society, the Fujifilm Group will actively support employee wellness initiatives designed to inspire our employees to improve their physical and mental wellbeing so they can be energetic and have a zest for life in this era of longer life expectancy.

<Main initiatives for Health & Productivity Management>
1) Building a health-oriented corporate culture
  • Posting, on the Intranet, health-related commitments made by all executive officers of Fujifilm and Fuji Xerox as well as the presidents of their Japanese subsidiaries, including a no-smoking declaration and commitment to undergo upper endoscopy and colonoscopy
  • Providing all employees in Japan with an annual e-learning program on wellness, under the guidance of an occupational physician, since fiscal year ending March 2020 (FY2019)
2) Measures for cancer
  • Setting the numerical target of “raising the percentage of Group employees in Japan receiving cancer screening (for stomach cancer, colorectal cancer, breast cancer and cervical cancer) to at least 90%*2 by FY2022”
  • Offering upper endoscopy and colonoscopy at the company’s medical facilities that use its endoscopic technology, such as the Fujifilm Nishi-Azabu Medical Center at Fujifilm’s headquarters
3) Measures for smoking
  • Setting the numerical target of “reducing the percentage of smoker of Group employees in Japan to 12% by FY2022”
  • Updating the Employment Regulations to include a smoking ban during working hours in April 2020, and closing all smoking areas on company premises in Japan in October of the same year
  • Collaborating with the Health Insurance Association to launch an online smoking-cessation program in FY2018 to support employees quit smoking

Today, Fujifilm conducts its business in a wide variety of fields as a comprehensive healthcare company covering prevention, diagnosis and treatment. In the category of diagnosis, the company supplies medical devices such as endoscopy, ultrasound system and digital mammography that support early detection of lifestyle diseases and cancer for greater improvement in the quality of healthcare and promotion of human health.

The Fujifilm Group will continue to work on solving social issues through these business activities, and accelerate its initiatives for maintaining and promoting employees’ wellness as a way of contributing to the establishment of healthy society with longevity.

  • *1 “Health and Productivity Management” is a registered trademark of the Workshop for the Management of Health on Company and Employee.
  • *2 The percentage of employees receiving screening for stomach cancer, colorectal cancer, breast cancer and cervical cancer. This target covers employees in Japan aged 35 and 40 or above for stomach cancer and colorectal cancer respectively, and all female employees in Japan for breast cancer and cervical cancer.
Corporate Philosophy —The Unchanging Values of the Fujifilm Group

We will use leading-edge, proprietary technologies to provide top-quality products and services that contribute to the advancement of culture, science, technology and industry, as well as improved health and environmental protection in society. Our overarching aim is to help enhance the quality of life of people worldwide.

Vision—Fujifilm Group's Ideals

Anchored by an open, fair and clear corporate culture and with leading-edge, proprietary technologies, Fujifilm is determined to remain a leading company by boldly taking up the challenge of developing new products and creating new value.

Contact

  Media contact

FUJIFILM Holdings Corporation
Corporate Communications Division
Public Relations Group

  • * Please note that the contents in this website are current as of the date of the press announcement and may be subject to change without prior notice. Information in each release, including the product availability, specification, prices, contacts, are those at the time of publication.